palopegteriparatide (Pending FDA Approval)

Brand and Other Names:TransCon PTH
  • Print
Sections

Dosing & Uses

Hypoparathyroidism

Pending FDA approval for hypoparathyroidism

Next:

Pharmacology

Mechanism of Action

Prodrug of parathyroid hormone (PTH) 1-34; it is bound to a linker and pegylated carrier that prevents binding to the PTH1R to extend the drug’s half-life

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.